Literature DB >> 14756673

The clinical picture of the Börjeson-Forssman-Lehmann syndrome in males and heterozygous females with PHF6 mutations.

G Turner1, K M Lower, S M White, M Delatycki, A K Lampe, M Wright, J Clayton Smith, B Kerr, S Schelley, H E Hoyme, B B A De Vries, T Kleefstra, M Grompe, B Cox, J Gecz, M Partington.   

Abstract

The usual description of the Börjeson-Forssman-Lehmann syndrome (BFLS) is that of a rare, X-linked, partially dominant condition with severe intellectual disability, epilepsy, microcephaly, coarse facial features, long ears, short stature, obesity, gynecomastia, tapering fingers, and shortened toes. Recently, mutations have been identified in the PHF6 gene in nine families with this syndrome. The clinical history and physical findings in the affected males reveal that the phenotype is milder and more variable than previously described and evolves with age. Generally, in the first year, the babies are floppy, with failure to thrive, big ears, and small external genitalia. As schoolboys, the picture is one of learning problems, moderate short stature, with emerging truncal obesity and gynecomastia. Head circumferences are usually normal, and macrocephaly may be seen. Big ears and small genitalia remain. The toes are short and fingers tapered and malleable. In late adolescence and adult life, the classically described heavy facial appearance emerges. Some heterozygous females show milder clinical features such as tapering fingers and shortened toes. Twenty percent have significant learning problems, and 95% have skewed X inactivation. We conclude that this syndrome may be underdiagnosed in males in their early years and missed altogether in isolated heterozygous females.

Entities:  

Mesh:

Year:  2004        PMID: 14756673     DOI: 10.1111/j.0009-9163.2004.00215.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  26 in total

Review 1.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

Review 2.  Pathogenesis of Börjeson-Forssman-Lehmann syndrome: Insights from PHF6 function.

Authors:  Arezu Jahani-Asl; Cheng Cheng; Chi Zhang; Azad Bonni
Journal:  Neurobiol Dis       Date:  2016-09-12       Impact factor: 5.996

Review 3.  Seizures and X-linked intellectual disability.

Authors:  Roger E Stevenson; Kenton R Holden; R Curtis Rogers; Charles E Schwartz
Journal:  Eur J Med Genet       Date:  2012-02-08       Impact factor: 2.708

4.  Mutation screening in Borjeson-Forssman-Lehmann syndrome: identification of a novel de novo PHF6 mutation in a female patient.

Authors:  J Crawford; K M Lower; R C M Hennekam; H Van Esch; A Mégarbané; S A Lynch; G Turner; J Gécz
Journal:  J Med Genet       Date:  2005-07-01       Impact factor: 6.318

5.  The X-linked intellectual disability protein PHF6 associates with the PAF1 complex and regulates neuronal migration in the mammalian brain.

Authors:  Chi Zhang; Luis A Mejia; Ju Huang; Pamela Valnegri; Eric J Bennett; Julius Anckar; Arezu Jahani-Asl; Gilbert Gallardo; Yoshiho Ikeuchi; Tomoko Yamada; Michael Rudnicki; J Wade Harper; Azad Bonni
Journal:  Neuron       Date:  2013-06-19       Impact factor: 17.173

6.  Chromatin regulators and their impact on DNA repair and G2 checkpoint recovery.

Authors:  Veronique A J Smits; Ignacio Alonso-de Vega; Daniël O Warmerdam
Journal:  Cell Cycle       Date:  2020-07-30       Impact factor: 4.534

7.  Structural and functional insights into the human Börjeson-Forssman-Lehmann syndrome-associated protein PHF6.

Authors:  Zhonghua Liu; Fudong Li; Ke Ruan; Jiahai Zhang; Yide Mei; Jihui Wu; Yunyu Shi
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

8.  PHF6 regulates cell cycle progression by suppressing ribosomal RNA synthesis.

Authors:  Jiadong Wang; Justin Wai-chung Leung; Zihua Gong; Lin Feng; Xiaobing Shi; Junjie Chen
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

9.  PHF6 mutations in T-cell acute lymphoblastic leukemia.

Authors:  Pieter Van Vlierberghe; Teresa Palomero; Hossein Khiabanian; Joni Van der Meulen; Mireia Castillo; Nadine Van Roy; Barbara De Moerloose; Jan Philippé; Sara González-García; María L Toribio; Tom Taghon; Linda Zuurbier; Barbara Cauwelier; Christine J Harrison; Claire Schwab; Markus Pisecker; Sabine Strehl; Anton W Langerak; Jozef Gecz; Edwin Sonneveld; Rob Pieters; Elisabeth Paietta; Jacob M Rowe; Peter H Wiernik; Yves Benoit; Jean Soulier; Bruce Poppe; Xiaopan Yao; Carlos Cordon-Cardo; Jules Meijerink; Raul Rabadan; Frank Speleman; Adolfo Ferrando
Journal:  Nat Genet       Date:  2010-03-14       Impact factor: 38.330

10.  Familial interstitial Xq27.3q28 duplication encompassing the FMR1 gene but not the MECP2 gene causes a new syndromic mental retardation condition.

Authors:  Marlène Rio; Valérie Malan; Sarah Boissel; Annick Toutain; Ghislaine Royer; Stéphanie Gobin; Nicole Morichon-Delvallez; Catherine Turleau; Jean-Paul Bonnefont; Arnold Munnich; Michel Vekemans; Laurence Colleaux
Journal:  Eur J Hum Genet       Date:  2009-10-21       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.